Abstract: Ecthyma gangrenosum is a rare skin infection classically associated with Pseudomonas aeruginosa. We performed a retrospective study of all cases diagnosed with ecthyma gangrenosum from 2004-2010 in a university hospital in Mexico (8 cases, 5 female patients and 3 male patients, ages between 4 months and 2 years). The most common risk factor for ecthyma gangrenosum is neutropenia in immunocompromised patients. In previously healthy patients, immunological evaluation is important to rule out underlying immunodeficiency. Ecthyma gangrenosum in healthy patients has a high mortality rate and early diagnosis and aggressive antibiotic treatment is imperative as it can improve patients' prognosis.
INTRODUCTION
Ecthyma gangrenosum (EG) is a rare skin infection classically associated with Pseudomona aeruginosa. It can be a potentially fatal systemic infection and can be a manifestation of an underlying clinical entity. [1] [2] [3] We performed a retrospective study of all EG cases from 2004 to 2010 in a university hospital in Monterrey, Mexico.
CASE REPORT
We report 8 cases that occurred with 5 female patients and 3 male patients, ages between 4 months and 2 years. Four patients were apparently previously healthy at admission, and the other 4 had a degree of immunosuppression (hemophagocytic lymphohistiocytosis, undifferentiated embryonic liver sarcoma and desnutrition (Table 1) ). All patients presented at our institution in a febrile state. They also had a history of erythema that progressed to pustules and ulcerations surrounded by erythema, some of them covered by a necrotic crust. Two patients had the lesions on the face, 3
on the extremities, 1 in the supraclavicular region, 1 in the gluteal region, and 1 on the face and extremities (Figures 1 and 2 ). 
DISCUSSION
The most common risk factor for EG is neutropenia in immunocompromised patients. Although it rarely occurs in previously healthy patients, 50% of these patients reveal a primary subclinical immunodeficiency or underwent recent antibiotic therapy. 2, 4 In previously healthy patients, the immunological evaluation is important to rule out underlying immunodeficiencies. Two types of EG have been described: the classical or bacteremic form, secondary to hematogenous spread; and the localized EG or nonsepticemic form, in which the lesion is located at the site of inoculation of the organism into the skin. 1 Antibiotic therapy with spectrum for Pseudomonas aeruginosa includes aminoglycosides, third-and fourth-generation cephalosporins, β-lactam antibiotics, and broad-spectrum penicillins.
In addition to the results of susceptibility tests for the isolate from the patient, local patterns of susceptibility for each hospital should be considered in the initial choice of treatment. Some studies comparing combination therapy with monotherapy reveal that the regimens do not affect mortality rates. [5] [6] [7] Prognosis depends on the host and on the degree of immunosuppression. 4 The disease has a high mortality rate. In patients with EG and septicemia secondary to Pseudomonas, it ranges from 38%-77%, and in patients with no sepsis, it is described in about 15%. 8 The most important prognostic factor of mortality in invasive
Ecthyma gangrenosum: a report of eight casesforms is the presence of neutropenia at diagnosis. 9 Luigi et al. reported that severe sepsis by P. aeuruginosa can occur in previously healthy children with a mortality rate of 55%.
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Immunological evaluation is essential in all the patients (including the apparently healthy ones) as immunosuppression can drastically change the prognosis. EG in healthy patients has a high mortality rate and early diagnosis and aggressive antibiotic treatment is imperative as it can improve the patient's prognosis. q
